The expression of interleukin-22 and S100A7, A8, A9 mRNA in patients with psoriasis vulgaris

Houjun Liu , Kun Huang , Yan Wu , Nengxing Lin , Jiawen Li , Yating Tu

Current Medical Science ›› 2007, Vol. 27 ›› Issue (33) : 605 -607.

PDF
Current Medical Science ›› 2007, Vol. 27 ›› Issue (33) : 605 -607. DOI: 10.1007/s11596-007-0533-z
Article

The expression of interleukin-22 and S100A7, A8, A9 mRNA in patients with psoriasis vulgaris

Author information +
History +
PDF

Abstract

In order to study the expression of interleukin-22 (IL-22) and S100A7, A8, A9 mRNA in the skin lesions of patients with psoriasis vulgaris and their relationship, the biopsies were taken from skin lesions in 35 patients with psoriasis vulgaris and the skin of 16 normal controls, and the expression levels of IL-22 and S100A7, A8 and A9 mRNA were detected by semi-quantitative RT-PCR. The results showed that (1) IL-22 and S100A8, A9 mRNA were positively expressed in the psoriatic skin lesions but negatively expressed in the normal controls; The expression level of S100A7 was (1.133±0.040) in the psoriatic skin lesions, significantly higher than that in the normal controls (0.744±0.037, P<0.01). (2) There were significantly positive correlations between the expression of IL-22/S100A7 mRNA, IL-22/S100A8 mRNA, IL-22/S100A9 mRNA in the psoriasis vulgaris (r1=0.543, r2=0.774, r3=0.621, P<0.01). It was concluded that IL-22 and S100A7, A8, A9 might play important roles in the occurrence and progression of psoriasis.

Keywords

psoriasis vulgaris / interleukin-22 / S100A7 / S100A8 / S100A9

Cite this article

Download citation ▾
Houjun Liu, Kun Huang, Yan Wu, Nengxing Lin, Jiawen Li, Yating Tu. The expression of interleukin-22 and S100A7, A8, A9 mRNA in patients with psoriasis vulgaris. Current Medical Science, 2007, 27(33): 605-607 DOI:10.1007/s11596-007-0533-z

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

DumoutierL., LouahedJ., RenauldJ. C.. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol, 2000, 164(4): 1814-1819

[2]

WolkK., KunzS., AsadullahK., et al.. Cutting edge: immune cells as sources and targets of the IL-10 family members?. J Immunol, 2002, 168(11): 5397-5402

[3]

DumoutierL., RoostE. V., ColauD., et al.. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as a hepatocyte-stimulating factor. Proc Natl Acad Sci USA, 2000, 97(18): 10 144-10 149

[4]

AggarwalS., XieM. H., MaruokaK., et al.. Acinar cells of the pancreas are a target of interleukin-22. J Interferon Cytokine Res, 2001, 21(12): 1047-1053

[5]

WolkK., KunzS., WitteE., et al.. IL-22 increases the innate immunity of tissues. Immunity, 2004, 21(2): 241-254

[6]

MischkeD., KordeB. P., MarenholzI., et al.. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex (epidermal differentiation complex) on human chromosome 1q21. J Invest Dermatol, 1996, 106(5): 989-992

[7]

BonifaceK., BernardF. X., GarciaM., et al.. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol, 2005, 174(6): 3695-3702

[8]

JinquanT., VorumH., LarsenC. G., et al.. Psoriasin: A novel chemotactic protein. J Invest Dermatol, 1996, 107(1): 5-10

[9]

ThoreyI. S., RothJ., RegenbogenJ., et al.. The Ca2+-binding protein S100A8 and S100A9 are encoded by novel injury-regulated genes. J Biol Chem, 2001, 276(38): 35 818-35 825

[10]

EckertR. L., BroomeA. M., RuseM., et al.. S100 proteins in the epidermis. J Invest Dermatol, 2004, 123(1): 23-33

AI Summary AI Mindmap
PDF

102

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/